Global Health Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Aug-2025.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.4 pts more than Nifty Midcap 150 and 6.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Global Health Limited (Medanta) announced strong Q1 FY26 results with consolidated revenue rising ~20% to Rs. 1,030.8 crore and profit after tax jumping ~50% to Rs. 159 crore, driven by higher patient volumes and operational efficiencies. On a standalone basis, revenue grew ~16% to Rs. 882.2 crore while PAT rose ~40% to Rs. 152 crore. The board fixed August 22, 2025 as the record date for a final dividend of Rs. 0.50 per equity share for FY25, subject to shareholder approval at the September 19, 2025 AGM. The board also recommended re-appointment of Dr. Naresh Trehan as Chairman & MD for another 5 years from August 2026, and re-appointed two independent directors. MAKS & Co was appointed as new Secretarial Auditor for 5 years from FY26. Comparative figures were restated due to the amalgamation of Medanta Holdings Private Limited with the company.
Strong Q1 earnings with double-digit revenue growth and ~50% PAT growth signal robust operational performance, likely to support positive investor sentiment. The Rs. 0.50 final dividend rewards shareholders, while continuity in leadership with Dr. Trehan's re-appointment provides stability. The restated financials from the amalgamation may temporarily distort year-on-year comparisons.